User profiles for "author:Eirik Ikdahl"

Eirik Ikdahl

Akershus Universitetssykehus
Verified email at ahus.no
Cited by 1574

Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis

AG Semb, E Ikdahl, G Wibetoe, C Crowson… - Nature Reviews …, 2020 - nature.com
Patients with rheumatoid arthritis (RA) are at high risk of developing cardiovascular disease
(CVD). Inflammation has a pivotal role in the pathogenesis of CVD. RA is an inflammatory …

[HTML][HTML] Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19

TV Lerum, TM Aaløkken, E Brønstad… - European …, 2021 - Eur Respiratory Soc
The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown.
We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest …

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

CS Crowson, S Rollefstad, E Ikdahl, GD Kitas… - Annals of the …, 2018 - ard.bmj.com
Objectives Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular
disease (CVD). We aimed to assess the impact of CVD risk factors, including potential sex …

Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis

E Ikdahl, S Rollefstad, G Wibetoe, IC Olsen… - The Journal of …, 2016 - jrheum.org
Objective. We evaluated the predictive value of these vascular biomarkers for cardiovascular
disease (CVD) events in patients with rheumatoid arthritis (RA): aortic pulse wave velocity …

[HTML][HTML] Cardiovascular disease risk profiles in inflammatory joint disease entities

G Wibetoe, E Ikdahl, S Rollefstad, IC Olsen… - Arthritis research & …, 2017 - Springer
Background Patients with inflammatory joint diseases (IJD) have increased risk of
cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with …

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients

IK Roelsgaard, E Ikdahl, S Rollefstad, G Wibetoe… - …, 2020 - academic.oup.com
Objectives Smoking is a major risk factor for the development of both cardiovascular disease
(CVD) and RA and may cause attenuated responses to anti-rheumatic treatments. Our aim …

Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases

E Ikdahl, G Wibetoe, S Rollefstad, A Salberg… - International journal of …, 2019 - Elsevier
Objectives Patients with inflammatory joint diseases (IJD) have an increased risk of
cardiovascular disease (CVD). Our goal was to examine indications for, and use of, lipid …

[HTML][HTML] Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis …

E Ikdahl, J Hisdal, S Rollefstad, IC Olsen… - Arthritis research & …, 2015 - Springer
Introduction Endothelial dysfunction is an early step in the atherosclerotic process and can
be quantified by flow-mediated vasodilation (FMD). Our aim was to investigate the effect of …

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit

AG Semb, S Rollefstad, E Ikdahl, G Wibetoe… - RMD open, 2021 - rmdopen.bmj.com
Aim The objective was to examine the prevalence of atherosclerotic cardiovascular disease
(ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and …

An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries

S Rollefstad, E Ikdahl, G Wibetoe… - European Heart …, 2022 - academic.oup.com
Aims To assess differences in estimated cardiovascular disease (CVD) risk among
rheumatoid arthritis (RA) patients from different world regions and to evaluate the …